Federal prime contract award
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
Description: IGF::OT::IGF
Award type: DEFINITIVE CONTRACT
Award amount: $695741475.58
Total outlays: $238756018.85
Period of performance: 2017-09-30 to 2027-09-29
NAICS: 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PSC: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Place of performance (state): NY